Basic Science research to discover potential cancer biomarker

Wednesday 21 December 2022
A new protein involved in breast cancer has been revealed by Dr Jeremy Drake (Victoria University) and a group of Australian and international collaborators.

Novel self-test for cancer monitoring - Tn Antigen 'blood prick' test

Wednesday 21 December 2022
Universal Biosensors, a Victorian based company, has obtained biospecimens from VCB for their international development clinical study. Their study aims to develop a handheld portable cancer biosensor for T and Tn Antigen using a “finger prick” blood test for measuring patient cancer remission and reoccurrence.

Supporting Bench to Bed Discovery – the Story of SubB2

Friday 10 December 2021
Professor Michael Jennings and his laboratory at Griffith University’s Institute of Glycomics, along with collaborators Prof James Patton and Prof A Patton at the University of Adelaide, have developed a novel technology for the early detection of various cancers including ovarian and breast cancer.

Perspective from a Biobank Donor – Wendy Harrold

Friday 10 December 2021
Wendy Harrold, donated her breast tissue to the Victorian Cancer Biobank after undergoing a preventative double mastectomy and reconstruction in 2018.

Improving cancer survival - supporting clinical trials

Thursday 22 October 2020
Professor Jeanne Tie from the Walter Eliza Hall Institute for Medical Research (WEHI) is pioneering the use of circulating tumour DNA (ctDNA) as an indicator for risk of cancer recurrence and treatment response in colorectal and pancreatic cancer.

Supporting Victorian biotechnology

Thursday 22 October 2020
Since 2008, the VCB has worked with CSIRO initially and later with Melbourne based start-up company Rhythm Biosciences Ltd to provide blood serum from over 500 cancer and control patients to develop a simple, inexpensive blood test using its pioneering ColoSTAT® technology.

Insights into cancer cell biology

Thursday 22 October 2020
While immunotherapy has shown some early promise in treating lung cancer, it has had limited benefits when targeting SCLC. Associate Professor Kate Sutherland from the WEHI is investigating why some patients are responding better to immunotherapy than others.

The Victorian Cancer Biobank through the Cancer Council Victoria as Lead Agency is supported by the Victorian Government through the Victorian Cancer Agency, a business unit of the Department of Health.

RAP Victorian Cancer Biobank would like to acknowledge the traditional custodians of the land on which we live and work. We would also like to pay respect to the elders past and present and extend that respect to all other Aboriginal people.

Jump to page top

Consortium members

Cancer Council Victoria Austin Health Eastern Health Monash Health Peter Mac Royal Melbourne Hospital

Supported by